299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00924547 (ClinicalTrials.gov)	November 2013	17/6/2009	Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis	Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis: Effects on Exhaled Pro-inflammatory Isoprostanes and Analysis of Its Esterification Sites in Plasma	Cystic Fibrosis	Dietary Supplement: Docosahexanoic Acid Supplement;Dietary Supplement: Placebo	Vanderbilt University	NULL	Completed	6 Years	N/A	Both	17	Phase 2	United States
2	NCT02690857 (ClinicalTrials.gov)	May 2010	16/2/2016	Study of Docosahexanoic Acid in Patients With Cystic Fibrosis (CF)	Efficacy of Docosahexanoic Acid on Lipid Peroxidation in Subjects With Cystic Fibrosis	Cystic Fibrosis	Drug: Docosahexaenoic acid;Drug: Sunflower Oil	Hospices Civils de Lyon	NULL	Completed	6 Years	30 Years	Male	10	Phase 2	NULL